2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Oland Thomas E | President | 1,551,480 | Aug 11, 2008 |
| Kummeth Charles R. | CEO | 1,186,938 | Aug 17, 2022 |
| Kelderman Kim | CEO | 801,711 | Nov 5, 2025 |
| Hippel James | CFO | 678,505 | Nov 5, 2025 |
| Herbert G A | — | 209,360 | Oct 24, 2008 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Mar 4, 2026 | Crouse Steven C. | President | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 4, 2026 | Crouse Steven C. | President | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 17, 2026 | Feb 19, 2026 | Herr Amy E. | Director | Sell | 22.5 | -1,976 | -40.69% | ✗ | $116.8K |
| Feb 3, 2026 | Feb 5, 2026 | Herr Amy E. | Director | Sell | 45.0 | -16 | -0.33% | ✗ | $1K |
| Feb 1, 2026 | Feb 3, 2026 | McManus Matthew | President | Sell | 22.5 | -1,665 | -17.80% | ✗ | $106.7K |
| Nov 3, 2025 | Nov 5, 2025 | Kelderman Kim | CEO | Sell | 22.5 | -2,303 | -4.52% | ✗ | $144.1K |
| Nov 3, 2025 | Nov 5, 2025 | Hippel James | CFO | Sell | 20.0 | -11,865 | -7.68% | ✗ | $742.4K |
| Nov 3, 2025 | Nov 5, 2025 | Geist William | President | Sell | 20.0 | -4,520 | -18.06% | ✗ | $282.8K |
| Oct 30, 2025 | Nov 3, 2025 | Bushman Julie L | Director | Neutral | 90.0 | +1,640 | 22.99% | ✗ | - |
| Oct 30, 2025 | Nov 3, 2025 | KEEGAN JOSEPH D | Director | Neutral | 90.0 | +1,640 | 11.91% | ✗ | - |
| Oct 30, 2025 | Nov 3, 2025 | HIGGINS JOHN L | Director | Neutral | 82.5 | +1,640 | 2.51% | ✗ | - |
| Oct 30, 2025 | Nov 3, 2025 | Seth Alpna | Director | Neutral | 90.0 | +1,640 | 11.91% | ✗ | - |
| Oct 30, 2025 | Nov 3, 2025 | Herr Amy E. | Director | Neutral | 90.0 | +1,640 | 51.35% | ✗ | - |
| Oct 30, 2025 | Nov 3, 2025 | Klimovsky Judith V. | Director | Neutral | 90.0 | +1,640 | 76.56% | ✗ | - |
| Oct 30, 2025 | Nov 3, 2025 | Vessey Rupert | Director | Neutral | 90.0 | +1,640 | 17.55% | ✗ | - |
| Oct 30, 2025 | Nov 3, 2025 | BAUMGARTNER ROBERT V | Director | Neutral | 82.5 | +1,640 | 3.66% | ✗ | - |
| Aug 25, 2025 | Aug 27, 2025 | Nusse Roeland | Director | Sell | 20.0 | -17,040 | -27.66% | ✗ | $960.4K |
| Aug 25, 2025 | Aug 27, 2025 | BAUMGARTNER ROBERT V | Director | Sell | 20.0 | -17,040 | -27.53% | ✗ | $957.8K |
| Aug 15, 2025 | Aug 19, 2025 | Hippel James | CFO | Sell | 22.5 | -1,926 | -1.46% | ✗ | $103.2K |
| Aug 15, 2025 | Aug 19, 2025 | Herr Amy E. | Director | Sell | 27.5 | -101 | -3.07% | ✗ | $5.4K |
| Aug 15, 2025 | Aug 19, 2025 | Kelderman Kim | CEO | Sell | 22.5 | -4,305 | -7.79% | ✗ | $230.7K |
| Aug 15, 2025 | Aug 19, 2025 | Bohnen Shane | SVP - General Counsel | Sell | 26.3 | -527 | -10.73% | ✗ | $28.2K |
| Aug 15, 2025 | Aug 19, 2025 | McManus Matthew | President | Sell | 26.3 | -880 | -15.67% | ✗ | $47.2K |
| Aug 15, 2025 | Aug 19, 2025 | Geist William | President | Sell | 26.3 | -803 | -5.05% | ✗ | $43K |
| Aug 7, 2025 | Aug 11, 2025 | HIGGINS JOHN L | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 29, 2025 | Jul 31, 2025 | Hippel James | CFO | Sell | 16.3 | -147,431 | -53.57% | ✗ | $8.6M |
| Jul 22, 2025 | Jul 24, 2025 | Kelderman Kim | CEO | Sell | 17.5 | -43,649 | -48.30% | ✗ | $2.3M |
| Jul 15, 2025 | Jul 17, 2025 | Kelderman Kim | CEO | Sell | 17.5 | -32,933 | -43.83% | ✗ | $1.7M |
| Jun 9, 2025 | Jun 11, 2025 | Herr Amy E. | Director | Sell | 22.5 | -1,280 | -29.80% | ✗ | $63.7K |
| May 1, 2025 | May 5, 2025 | HIGGINS JOHN L | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 1, 2019 | Apr 11, 2025 | VESSEY RUPERT | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 3, 2025 | Apr 7, 2025 | Bohnen Shane | SVP - General Counsel | Sell | 26.3 | -747 | -18.95% | ✗ | $41K |
| Feb 14, 2025 | Feb 18, 2025 | Herr Amy E. | Director | Sell | 22.5 | -1,860 | -38.15% | ✗ | $122.7K |
| Feb 3, 2025 | Feb 7, 2025 | Herr Amy E. | Director | Neutral | 90.0 | +1,040 | 55.91% | ✗ | - |
| Feb 7, 2025 | Herr Amy E. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 1, 2025 | Feb 4, 2025 | McManus Matthew | President | Sell | 22.5 | -1,642 | -35.54% | ✗ | $120.8K |
| Feb 1, 2025 | Feb 4, 2025 | Geist William | President | Sell | 22.5 | -1,109 | -7.70% | ✗ | $81.6K |
| Aug 15, 2024 | Feb 3, 2025 | McManus Matthew | President | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 27, 2025 | Jan 29, 2025 | Kelderman Kim | CEO | Sell | 17.5 | -13,392 | -25.56% | ✗ | $1M |
| Nov 1, 2024 | Nov 5, 2024 | Geist William | President | Sell | 22.5 | -3,270 | -22.79% | ✗ | $246.3K |
| Nov 1, 2024 | Nov 5, 2024 | Kelderman Kim | CEO | Sell | 22.5 | -2,430 | -5.86% | ✗ | $183K |
| Nov 1, 2024 | Nov 5, 2024 | Hippel James | CFO | Sell | 20.0 | -6,475 | -5.73% | ✗ | $487.6K |
| Oct 24, 2024 | Oct 28, 2024 | KEEGAN JOSEPH D | Director | Neutral | 90.0 | +1,462 | 11.88% | ✗ | - |
| Oct 24, 2024 | Oct 28, 2024 | VESSEY RUPERT | Director | Neutral | 90.0 | +1,462 | 18.54% | ✗ | - |
| Oct 24, 2024 | Oct 28, 2024 | Bushman Julie L | Director | Neutral | 90.0 | +1,462 | 25.77% | ✗ | - |
| Oct 24, 2024 | Oct 28, 2024 | HIGGINS JOHN L | Director | Neutral | 82.5 | +1,462 | 3.13% | ✗ | - |
| Oct 24, 2024 | Oct 28, 2024 | Nusse Roeland | Director | Neutral | 82.5 | +1,462 | 3.39% | ✗ | - |
| Oct 24, 2024 | Oct 28, 2024 | Seth Alpna | Director | Neutral | 90.0 | +1,462 | 11.88% | ✗ | - |
| Oct 24, 2024 | Oct 28, 2024 | Klimovsky Judith V | Director | Neutral | 90.0 | +1,462 | 215.00% | ✗ | - |
| Oct 24, 2024 | Oct 28, 2024 | BAUMGARTNER ROBERT V | Director | Neutral | 82.5 | +1,462 | 3.37% | ✗ | - |
| Sep 12, 2024 | Sep 16, 2024 | HIGGINS JOHN L | Director | Sell | 22.5 | -1,874 | -3.86% | ✗ | $137.2K |
| Aug 29, 2024 | Sep 3, 2024 | Kelderman Kim | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 15, 2024 | Aug 19, 2024 | Hippel James | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 15, 2024 | Aug 19, 2024 | Kelderman Kim | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 15, 2024 | Aug 19, 2024 | Geist William | President | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 15, 2024 | Aug 19, 2024 | Bohnen Shane | SVP - General Counsel | Sell | 37.5 | -15 | -0.88% | ✗ | $1.1K |
| Aug 15, 2024 | Aug 19, 2024 | McManus Matthew | President | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 8, 2024 | Aug 12, 2024 | BAUMGARTNER ROBERT V | Director | Sell | 17.5 | -16,000 | -26.94% | ✗ | $1.2M |
| Aug 2, 2024 | Aug 6, 2024 | Hippel James | CFO | Sell | 17.5 | -36,076 | -26.53% | ✗ | $3M |
| Jul 31, 2024 | Aug 2, 2024 | Kelderman Kim | CEO | Sell | 20.0 | -9,479 | -19.18% | ✗ | $777K |
| Jul 23, 2024 | Jul 25, 2024 | Hippel James | CFO | Sell | 17.5 | -24,282 | -22.63% | ✗ | $1.9M |
| Jul 8, 2024 | Jul 10, 2024 | HIGGINS JOHN L | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 14, 2024 | May 16, 2024 | HIGGINS JOHN L | Director | Sell | 20.0 | -4,000 | -9.85% | ✗ | $335.4K |
| May 1, 2024 | May 3, 2024 | Klimovsky Judith V | Director | Neutral | 90.0 | +680 | 100.00% | ✗ | - |
| May 3, 2024 | Klimovsky Judith V | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Apr 3, 2024 | Apr 5, 2024 | Bohnen Shane | SVP - General Counsel | Sell | 22.5 | -747 | -31.20% | ✗ | $50.7K |
| Mar 7, 2024 | Mar 11, 2024 | Nusse Roeland | Director | Sell | 20.0 | -10,400 | -19.44% | ✗ | $800.6K |
| Feb 1, 2024 | Feb 5, 2024 | Geist William | President | Sell | 22.5 | -1,111 | -12.53% | ✗ | $76.1K |
| Feb 1, 2024 | Feb 5, 2024 | McManus Matthew | President | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 5, 2024 | McManus Matthew | President | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 1, 2024 | Feb 5, 2024 | Kelderman Kim | COO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 19, 2023 | Dec 21, 2023 | Hippel James | CFO | Sell | 17.5 | -32,966 | -31.44% | ✗ | $2.6M |
| Aug 15, 2023 | Dec 14, 2023 | Geist William | President | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 15, 2023 | Dec 14, 2023 | Bohnen Shane | SVP - General Counsel | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 15, 2023 | Dec 14, 2023 | Kelderman Kim | Pres. Diagnostics & Genom | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 15, 2023 | Dec 14, 2023 | Hippel James | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 1, 2023 | Nov 9, 2023 | Geist William | President | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 1, 2023 | Nov 3, 2023 | Geist William | President | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 1, 2023 | Nov 3, 2023 | Hippel James | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 1, 2023 | Nov 3, 2023 | Kelderman Kim | COO | Neutral | 90.0 | +14,196 | 66.88% | ✗ | - |
| Oct 26, 2023 | Oct 30, 2023 | Seth Alpna | Director | Neutral | 90.0 | +1,625 | 15.21% | ✗ | - |
| Oct 26, 2023 | Oct 30, 2023 | Bushman Julie L | Director | Neutral | 90.0 | +1,625 | 40.14% | ✗ | - |
| Oct 26, 2023 | Oct 30, 2023 | VESSEY RUPERT | Director | Neutral | 90.0 | +1,625 | 25.96% | ✗ | - |
| Oct 26, 2023 | Oct 30, 2023 | STEER RANDOLPH C | Director | Neutral | 85.0 | +1,625 | 7.20% | ✗ | - |
| Oct 26, 2023 | Oct 30, 2023 | HIGGINS JOHN L | Director | Neutral | 82.5 | +1,625 | 4.65% | ✗ | - |
| Oct 26, 2023 | Oct 30, 2023 | KEEGAN JOSEPH D | Director | Neutral | 90.0 | +1,625 | 15.21% | ✗ | - |
| Oct 26, 2023 | Oct 30, 2023 | Nusse Roeland | Director | Neutral | 82.5 | +1,625 | 3.13% | ✗ | - |
| Oct 26, 2023 | Oct 30, 2023 | BAUMGARTNER ROBERT V | Director | Neutral | 82.5 | +1,625 | 3.89% | ✗ | - |
| Aug 30, 2023 | Sep 1, 2023 | Nusse Roeland | Director | Sell | 20.0 | -8,939 | -14.70% | ✗ | $718K |
| Aug 24, 2023 | Aug 28, 2023 | Kelderman Kim | Pres. Diagnostics & Genom | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 15, 2023 | Aug 24, 2023 | Bohnen Shane | SVP - General Counsel | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 15, 2023 | Aug 17, 2023 | Hippel James | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 15, 2023 | Aug 17, 2023 | Kelderman Kim | Pres. Diagnostics & Genom | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 15, 2023 | Aug 17, 2023 | Bohnen Shane | SVP - General Counsel | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 15, 2023 | Aug 17, 2023 | Kummeth Charles R. | CEO | Sell | 30.0 | -8,675 | -0.67% | ✗ | $734K |
| Aug 15, 2023 | Aug 17, 2023 | Geist William | President | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 9, 2023 | Aug 11, 2023 | Kummeth Charles R. | CEO | Neutral | 37.5 | -9,008 | -0.70% | ✗ | - |
| Aug 5, 2023 | Aug 8, 2023 | Kummeth Charles R. | CEO | Sell | 17.5 | -31,962 | -2.44% | ✗ | $2.6M |
| Aug 5, 2023 | Aug 8, 2023 | Hippel James | CFO | Sell | 20.0 | -6,335 | -9.91% | ✗ | $520.5K |
| Aug 5, 2023 | Aug 8, 2023 | Kelderman Kim | Pres. Diagnostics & Genom | Sell | 20.0 | -4,139 | -17.79% | ✗ | $340.1K |